Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1989;65:546-553

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hall, J. A.
Right arrow Articles by Brown, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hall, J. A.
Right arrow Articles by Brown, M. J.

Circulation Research, Vol 65, 546-553, Copyright © 1989 by American Heart Association


ARTICLES

Intracoronary injections of salbutamol demonstrate the presence of functional beta 2-adrenoceptors in the human heart

JA Hall, MC Petch and MJ Brown
Clinical Pharmacology Unit, Addenbrooke's Hospital, Cambridge, England.

To demonstrate the presence of functional cardiac beta 2-adrenoceptors in man, we studied the responses to intracoronary injections of salbutamol in three groups of six patients. We injected salbutamol, a selective beta 2-adrenoceptor agonist, into the right coronary artery to avoid peripheral vasodilator action and to stimulate the sinoatrial node directly. Salbutamol injections caused a sinus tachycardia. The same doses of salbutamol injected into the aortic root caused no change in heart rate, ruling out a systemic effect. The mean dose required to cause an increase in heart rate of 30 beats/min (IHR30) was 2.6 micrograms in the first group of six patients. In 12 other patients salbutamol was given after beta-blockade to confirm the beta 2- selectivity of the responses. Doses of practolol (beta 1-selective blockade) and of propranolol (beta 1- and beta 2-blockade) that had equal beta 1-blocking activity were used. In six patients who were given practolol, the mean IHR30 dose was 2.1 micrograms. In six patients who were given propranolol, the mean IHR30 dose was significantly greater at 64 micrograms (p less than 0.001, practolol vs. propranolol). This study demonstrates that direct cardiac beta 2- adrenoceptor stimulation in man has a positive chronotropic effect.


This article has been cited by other articles:


Home page
ChestHome page
E. M. Kallergis, E. G. Manios, E. M. Kanoupakis, S. E. Schiza, H. E. Mavrakis, N. K. Klapsinos, and P. E. Vardas
Acute Electrophysiologic Effects of Inhaled Salbutamol in Humans
Chest, June 1, 2005; 127(6): 2057 - 2063.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. W. Waters, S. H. Platts, B. M. Mitchell, P. A. Whitson, and J. V. Meck
Plasma volume restoration with salt tablets and water after bed rest prevents orthostatic hypotension and changes in supine hemodynamic and endocrine variables
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H839 - H847.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Barbuti, B. Gravante, M. Riolfo, R. Milanesi, B. Terragni, and D. DiFrancesco
Localization of Pacemaker Channels in Lipid Rafts Regulates Channel Kinetics
Circ. Res., May 28, 2004; 94(10): 1325 - 1331.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M. J Brown
A RATIONAL BASIS FOR SELECTION AMONG DRUGS OF THE SAME CLASS
Heart, June 1, 2003; 89(6): 687 - 694.
[Full Text] [PDF]


Home page
HeartHome page
M D Lowe, E Rowland, M J Brown, and A A Grace
{beta}2 Adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium
Heart, July 1, 2001; 86(1): 45 - 51.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
O.-E. Brodde and M. C. Michel
Adrenergic and Muscarinic Receptors in the Human Heart
Pharmacol. Rev., December 1, 1999; 51(4): 651 - 690.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. E. Newton, E. R. Azevedo, and J. D. Parker
Inotropic and Sympathetic Responses to the Intracoronary Infusion of a ß2-Receptor Agonist : A Human In Vivo Study
Circulation, May 11, 1999; 99(18): 2402 - 2407.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J G Crilley, J H Dark, and J A Hall
Reversal of severe pulmonary hypertension with beta  blockade in a patient with end stage left ventricular failure
Heart, December 1, 1998; 80(6): 620 - 622.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. Castellano and M. Bohm
The Cardiac ß-Adrenoceptor–Mediated Signaling Pathway and Its Alterations in Hypertensive Heart Disease
Hypertension, March 1, 1997; 29(3): 715 - 722.
[Abstract] [Full Text]


Home page
BMJHome page
M. J Brown
To (ss) block or better block?
BMJ, September 16, 1995; 311(7007): 701 - 702.
[Full Text]


Home page
CirculationHome page
F. H.H. Leenen, R. A. Davies, and A. Fourney
Role of Cardiac ß2-Receptors in Cardiac Responses to Exercise in Cardiac Transplant Patients
Circulation, February 1, 1995; 91(3): 685 - 690.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
V. Kuznetsov, E. Pak, R. B. Robinson, and S. F. Steinberg
ß2-Adrenergic Receptor Actions in Neonatal and Adult Rat Ventricular Myocytes
Circ. Res., January 1, 1995; 76(1): 40 - 52.
[Abstract] [Full Text]